abagovomab 33
abciximab 24
abituzumab 24
abrilumab 13
actoxumab 11
adalimumab 15
aducanumab 11
afasevikumab 12
alacizumab_pegol 8
alemtuzumab 26
alirocumab 16
amatuximab 35
andecaliximab 21
anifrolumab 18
anrukinzumab 17
aprutumab 17
aprutumab_ixadotin 17
arcitumomab 17
ascrinvacumab 4
atezolizumab 14
atinumab 15
avelumab 9
basiliximab 25
bavituximab 29
begelomab 23
benralizumab 26
bevacizumab_beta 21
bezlotoxumab 11
bimagrumab 15
bleselumab 12
blinatumomab 28
blosozumab 29
bococizumab 17
brazikumab 19
brentuximab_vedotin 22
briakinumab 20
brodalumab 10
brolucizumab 28
brontictuzumab 25
burosumab 18
cabiralizumab 27
camrelizumab 13
canakinumab 23
cantuzumab_ravtansin 37
carlumab 13
carotuximab 13
cergutuzumab_amunaleukin2 26
cergutuzumab_amunaleukin 26
certolizumab_pegol 27
cetiximab 37
citatuzumab_bogatox 28
cixutumumab 25
clivatuzumab_tetraxetan 21
codrituzumab 22
conatumumab 13
concizumab 18
crenezumab 19
crizanlizumab 23
crotedumab 20
dacetuzumab 22
daclizumab 16
dalotuzumab 27
dapirolizumab_pegol 23
daratumumab 12
dectrekumab 10
demcizumab 22
denosumab 8
depatuxizumab 19
depatuxizumab_mafodotin 19
dezamizumab 22
dinutuximab 31
diridavumab 21
domagrozumab 16
drozitumab 16
duligotuzumab 20
durvalumab 9
dusigitumab 20
efalizumab 36
efungumab 22
eldelumab 15
elezanumab 17
elgemtumab 10
elotuzumab 16
emactuzumab 16
emapalumab 25
emibetuzumab 19
enavatuzumab 24
enfortumab_vedotin 14
enoblituzumab 17
enokizumab 26
enoticumab 19
ensituximab 26
eptinezumab 13
erenumab 22
etaracizumab 14
etrolizumab 23
evinacumab 21
evolocumab 16
farletuzumab 3
fasinumab 17
fezakinumab 22
fibatuzumab 9
ficlatuzumab 25
firivumab 25
flanvotumab 17
fletikumab 24
foralumab 14
foravirumab 16
fremanezumab 30
fresolimumab 16
fulranumab 20
futuximab 18
galcanezumab 15
ganitumab 20
gantenerumab 13
gemetuzumab 29
gemtuzumab2 19
gemtuzumab 23
gevokizumab 21
girentuximab 27
glembatumumab 18
glembatumumab_vedotin 18
guselkumab 20
ibalizumab 29
ibritumomab 22
icrucumab 12
idarucizumab 24
ifabotuzumab 9
imalumab 15
imgatuzumab 21
inclacumab 20
indatuximab_ravtansin 25
indusatumab 18
inebilizumab 22
intetumumab 10
iodine_girentuximab 29
ipilimumab 5
iratumumab 8
isatuximab 33
itolizumab 22
ixekizumab 26
labetuzumab_govitecan 24
lambrolizumab 28
lampalizumab 25
lanadelumab 19
landogrozumab 15
laprituximab 31
lebrikizumab 30
lendalizumab 25
lenzilumab 16
lifastuzumab_vedotin 24
ligelizumab 23
lilotomab 29
lirilumab 21
lodelcizumab 16
lokivetmab 16
lorvotuzumab_mertansin 18
lucatumumab 30
lumretuzumab 19
lupartumab 18
lutikizumab 16
margetuximab 30
milatuzumab 28
mirvetuximab 35
mirvetuximab_soravtansin 35
modotuximab 39
mogamulizumab 22
monalizumab 19
motavizumab 28
moxetumomab_pasudotox 19
namilumab 20
naratuximab 29
naratuximab_emtansin 29
narnatumab 16
navicixizumab2 28
navicixizumab 24
navivumab 30
necitumumab 10
nemolizumab 27
nesvacumab 14
nivolumab 13
obiltoxaximab 21
obinutuzumab 30
ocaratuzumab 21
ofatumumab 14
olaratumab 14
olokizumab 24
omalizumab 18
onartuzumab 22
ontuxizumab 28
opicinumab 13
orticumab 12
otelixizumab 38
oxelumab 10
ozanezumab 25
pamrevlumab 11
panobacumab 19
parsatuzumab 30
pasotuxizumab 17
pateclizumab 15
patritumab 18
pembrolizumab 28
perakizumab 22
pidilizumab 15
pinatuzumab_vedotin 16
plozalizumab 23
pogalizumab 25
polatuzumab_vedotin 20
ponezumab 27
prezalumab 15
pritoxaximab 32
quilizumab 19
racotumomab 29
radretumab 13
ralpancizumab 22
ramucirumab 11
ranevetmab 28
ranibizumab 20
refanezumab 22
remtolumab 19
rilotumumab 14
rinucumab 16
risankizumab 31
rituximab 19
rivabazumab 23
robatumumab 20
roledumab 30
romosozumab 22
rontalizumab 22
rosmantuzumab 23
rozanolixizumab 20
sacituzumab 27
sacituzumab_govitecan 27
samalizumab 25
sapelizumab 22
sarilumab 17
secukinumab 15
seribantumab 15
setoxaximab 33
sifalimumab 10
siltuximab 20
simtuzumab 26
sirukumab 9
solanezumab 27
solitomab 23
stamulumab 15
suptavumab 22
suvizumab 15
tabalumab 18
tadocizumab 18
tamtuvetmab 29
tanezumab 21
tarextumab 11
tavolixizumab 12
telisotuzumab 31
teplizumab 17
tesidolumab 22
tezepelumab 23
tigatuzumab 15
tildrakizumab 21
timolumab 14
tisotumab 11
tosatoxumab 30
tositumomab 19
tralokinumab 30
trastuzumab 24
tregalizumab 21
trevogrumab 12
ublituximab 16
urelumab 14
ustekinumab 26
utomilumab 21
vadastuximab 26
vadastuximab_talirin 26
vandortuzumab_vedotin 18
vantictumab 17
vanucizumab2 21
vanucizumab 26
varlilumab 17
vatelizumab 19
vedolizumab 24
veltuzumab 10
vesencumab 9
vorsetuzumab 22
vorsetuzumab_mafodotin 22
vunakizumab 30
xentuzumab 17
zatuximab 39
